Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis

DSA McLeod, KF Watters, AD Carpenter… - The Journal of …, 2012 - academic.oup.com
Context: TSH is the major growth factor for thyrocytes and may have a causative role in
thyroid cancer. Objective: The objective of the study was to systematically assess the …

Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease

E Fiore, P Vitti - The Journal of Clinical Endocrinology & …, 2012 - academic.oup.com
Context: TSH is the main factor involved in the control of proliferation of thyrocytes. Recently,
a strong relationship between serum TSH and risk of thyroid malignancy has been reported …

American association of clinical endocrinologists, American college of endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice …

H Gharib, E Papini, JR Garber, DS Duick, RM Harrell… - Endocrine practice, 2016 - Elsevier
Thyroid nodules are detected in up to 50 to 60% of healthy subjects. Most nodules do not
cause clinically significant symptoms, and as a result, the main challenge in their …

Thyroid-stimulating hormone, thyroid hormones, and risk of papillary thyroid cancer: a nested case–control study

H Huang, J Rusiecki, N Zhao, Y Chen, S Ma, H Yu… - … Biomarkers & Prevention, 2017 - AACR
Background: The effects of thyroid-stimulating hormone (TSH) and thyroid hormones on the
development of human papillary thyroid cancer (PTC) remain poorly understood. Methods …

Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population

JM Han, TY Kim, MJ Jeon, JH Yim… - European journal of …, 2013 - academic.oup.com
Objective Obesity is a well-known risk factor for many cancers, including those of the
esophagus, colon, kidney, breast, and skin. However, there are few reports on the …

Thyroid nodule management: clinical, ultrasound and cytopathological parameters for predicting malignancy

FFR Maia, DE Zantut-Wittmann - Clinics, 2012 - SciELO Brasil
Although fine-needle aspiration cytology is considered to be the reference method for
evaluating thyroid nodules, the results are inaccurate in approximately 10-30% of cases …

Higher TSH level is a risk factor for differentiated thyroid cancer

HK Kim, JH Yoon, SJ Kim, JS Cho… - Clinical …, 2013 - Wiley Online Library
Objectives Higher thyroid‐stimulating hormone (TSH) levels are associated with
differentiated thyroid cancers (DTC). To validate this association, we compared TSH levels …

[HTML][HTML] Thyroid papillary microcarcinoma: etiology, clinical manifestations, diagnosis, follow-up, histopathology and prognosis

S Dideban, A Abdollahi, A Meysamie… - Iranian journal of …, 2016 - ncbi.nlm.nih.gov
Background: Thyroid carcinoma is the most common malignancy of the endocrine system.
Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer, accounting for …

Preoperative thyrotropin serum concentrations gradually increase from benign thyroid nodules to papillary thyroid microcarcinomas then to papillary thyroid cancers of …

C Zafon, G Obiols, JA Baena, J Castellví… - Journal of thyroid …, 2012 - Wiley Online Library
We evaluated the preoperative serum thyrotropin (TSH) levels in 386 patients operated on
for nodular thyroid disease (NTD). TSH levels for cases with final benign disease and …

The relationship between thyrotropin serum concentrations and thyroid carcinoma

X Zhang, L Tian, D Teng, W Teng - Cancers, 2023 - mdpi.com
Simple Summary Thyroid-stimulating hormone (TSH) plays a role in the regulation of thyroid
hormones and is an important indicator for assessing thyroid function. Thyroid cancer (TC) is …